plerixafor has been researched along with Mouth Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anqi, C; Eguchi, T; Kawai, H; Nagatsuka, H; Nakano, K; Okamoto, K; Oo, MW; Sukegawa, S; Takabatake, K; Yoshida, S | 1 |
| Kuribayashi, N; Miyamoto, Y; Nagai, H; Onoue, T; Tamatani, T; Tomizuka, Y; Uchida, D | 1 |
| Begum, NM; Miwa, Y; Onoue, T; Sato, M; Tomizuka, Y; Uchida, D; Yoshida, H | 1 |
3 other study(ies) available for plerixafor and Mouth Neoplasms
| Article | Year |
|---|---|
Tumor Angiogenic Inhibition Triggered Necrosis (TAITN) in Oral Cancer.
Topics: Adult; Aged; Aged, 80 and over; Animals; Benzylamines; Carcinoma, Squamous Cell; Cell Line, Tumor; Cyclams; Female; Heterocyclic Compounds; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Mouth Neoplasms; Neovascularization, Pathologic; Receptors, CXCR4 | 2019 |
Blockade of CXCR4 in oral squamous cell carcinoma inhibits lymph node metastases.
Topics: Animals; Antineoplastic Agents; Benzylamines; Carcinoma, Squamous Cell; Cyclams; Down-Regulation; Heterocyclic Compounds; Immunohistochemistry; Lymphatic Metastasis; Masseter Muscle; Mice; Mice, Inbred BALB C; Mice, Nude; Mouth Neoplasms; Neoplasm Transplantation; Receptors, CXCR4; RNA, Small Interfering; Transfection | 2011 |
Involvement of an autocrine stromal cell derived factor-1/CXCR4 system on the distant metastasis of human oral squamous cell carcinoma.
Topics: Aged; Aged, 80 and over; Animals; Autocrine Communication; Benzylamines; Carcinoma, Squamous Cell; Chemokine CXCL12; Chemokines, CXC; Cyclams; Female; Heterocyclic Compounds; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mice; Mice, Nude; Middle Aged; Mouth Neoplasms; Phenotype; Receptors, CXCR4; Survival Analysis | 2007 |